GPT and neoplasm: During conversion therapy, the non-recurrence group exhibited greater tumor shrinkage (5.67 ± 3.06 cm vs. 8.77 ± 3.92 cm; p<0.001), lower ALT (p=0.017), higher AST (p=0.008), and lower bilirubin (p=0.006).